Cadherins, catenins and cell cycle regulators: Impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial

Por Singh, Meenakshi, Darcy, Kathleen M., Brady, William E., Clubwala, Rashna, Weber, Zachary, Rittenbach, Jon V., Akalin, Ali, Whitney, Charles W., Zaino, Richard, Ramirez, Nilsa C., Leslie, Kimberly K.
Publicado em 2011

CA-125 cut-off value as a predictor for complete interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer

Por Furukawa, Naoto, Sasaki, Yoshikazu, Shigemitsu, Aiko, Akasaka, Juria, Kanayama, Seiji, Kawaguchi, Ryuji, Kobayashi, Hiroshi
Publicado em 2013

p16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping

Por Nishio, Sakiko, Fujii, Takuma, Nishio, Hiroshi, Kameyama, Kaori, Saito, Miyuki, Iwata, Takashi, Kubushiro, Kaneyuki, Aoki, Daisuke
Publicado em 2013

Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture

Por Suh, Dong Hoon, Kim, Tae Hun, Kim, Jae-Weon, Kim, Sun Young, Kim, Hee Seung, Lee, Taek Sang, Chung, Hyun Hoon, Kim, Yong-Beom, Park, Noh Hyun, Song, Yong Sang
Publicado em 2013

Recurrent ovarian cancer: Is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen?

Por McCann, Georgia A., Smith, Blair, Backes, Floor J., Rath, Kellie, Chacko, Simi, Salani, Ritu, Eisenhauer, Eric, Fowler, Jeffrey, Cohn, David, Copeland, Larry, O’Malley, David
Publicado em 2012

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I–IV uterine carcinosarcoma

Por Makker, Vicky, Abu-Rustum, Nadeem R., Alektiar, Kaled M., Aghajanian, Carol. A., Zhou, Qin, Iasonos, Alexia, Hensley, Martee. L.
Publicado em 2008

The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry

Por Mattes, Malcolm D., Lee, Jennifer C., Metzger, Daniel J., Ashamalla, Hani, Katsoulakis, Evangelia
Publicado no J Gynecol Oncol (2015)

Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer

Por Yoshida, Ken, Yamazaki, Hideya, Nakamura, Satoaki, Masui, Koji, Kotsuma, Tadayuki, Akiyama, Hironori, Tanaka, Eiichi, Yoshikawa, Nobuhiko, Uesugi, Yasuo, Shimbo, Taiju, Narumi, Yoshifumi, Yoshioka, Yasuo
Publicado no J Gynecol Oncol (2015)

Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis

Por Onuki, Mamiko, Matsumoto, Koji, Sakurai, Manabu, Ochi, Hiroyuki, Minaguchi, Takeo, Satoh, Toyomi, Yoshikawa, Hiroyuki
Publicado no J Gynecol Oncol (2016)

DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer

Por Kim, Mi-Kyung, Lee, In-Ho, Lee, Ki-Heon, Lee, Yoo Kyung, So, Kyeong A, Hong, Sung Ran, Hwang, Chang-Sun, Kee, Mee-Kyung, Rhee, Jee Eun, Kang, Chun, Hur, Soo Young, Park, Jong Sup, Kim, Tae-Jin
Publicado no J Gynecol Oncol (2016)

Diagnostic, therapeutic and evolutionary characteristics of cervical cancer in Department of Radiotherapy, Mohamed V Military Hospital – Rabat in Morocco

Por Elmarjany, Mohammed, Maghous, Abdelhak, Razine, Rachid, Marnouche, Elamin, Andaloussi, Khalid, Bazine, Amine, Lalya, Issam, Zaghba, Noha, Hadadi, Khalid, Sifat, Hassan, Habib, Baba, Kouach, Jaouad, Mansouri, Hamid
Publicado no Gynecol Oncol Res Pract (2015)

Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study

Por Minion, Lindsey E., Chase, Dana M., Farley, John H., Willmott, Lyndsay J., Monk, Bradley J.
Publicado no Gynecol Oncol Res Pract (2016)

Opportunistic salpingectomy for ovarian cancer prevention

Por Hanley, Gillian E., McAlpine, Jessica N., Kwon, Janice S., Mitchell, Gillian
Publicado no Gynecol Oncol Res Pract (2015)

Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success

Por Willows, Karla, Lennox, Genevieve, Covens, Allan
Publicado no Gynecol Oncol Res Pract (2016)

Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?

Por Sung, Yeoun Eun, Ki, Eun Young, Lee, Youn Soo, Hur, Soo Young, Lee, Ahwon, Park, Jong Sup
Publicado no J Gynecol Oncol (2016)

Disparities in the surgical staging of high-grade endometrial cancer in the United States

Por Foote, Jonathan R., Gaillard, Stephanie, Broadwater, Gloria, Sosa, Julie A., Davidson, Brittany, Adam, Mohamed A., Secord, Angeles Alvarez, Jones, Monica B., Chino, Junzo, Havrilesky, Laura J.
Publicado no Gynecol Oncol Res Pract (2017)

Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana

Por Obiri-Yeboah, Dorcas, Adu-Sarkodie, Yaw, Djigma, Florencia, Akakpo, Kafui, Aniakwa-Bonsu, Ebenezer, Amoako-Sakyi, Daniel, Jacques, Simpore, Mayaud, Philippe
Publicado no Gynecol Oncol Res Pract (2017)

Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial

Por Chekerov, Radoslav, Harter, Philipp, Fuxius, Stefan, Hanker, Lars Christian, Woelber, Linn, Müller, Lothar, Klare, Peter, Abenhardt, Wolfgang, Nedkova, Yoana, Yalcinkaya, Isil, Heinrich, Georg, Sommer, Harald, Mahner, Sven, Wimberger, Pauline, Koensgen-Mustea, Dominique, Richter, Rolf, Oskay-Oezcelik, Gülten, Sehouli, Jalid
Publicado no Gynecol Oncol Res Pract (2017)

Improved anti-tumor therapy based upon infectivity enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines

Por Numnum, T Michael, Makhija, Sharmila, Lu, Baogen, Wang, Minghui, Rivera, Angel, Stoff-Khalili, Mariam, Alvarez, Ronald D, Zhu, Zeng Bian, Curiel, David T
Publicado em 2007

ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas

Por Johnatty, Sharon E., Beesley, Jonathan, Gao, Bo, Chen, Xiaoqing, Lu, Yi, Law, Matthew H., Henderson, Michelle J., Russell, Amanda J., Hedditch, Ellen L., Emmanuel, Catherine, Fereday, Sian, Webb, Penelope M., Goode, Ellen L., Vierkant, Robert A., Fridley, Brooke L., Cunningham, Julie M, Fasching, Peter A., Beckmann, Matthias W., Ekici, Arif B., Hogdall, Estrid, Kjaer, Susanne K., Jensen, Allan, Hogdall, Claus, Brown, Robert, Paul, Jim, Lambrechts, Sandrina, Despierre, Evelyn, Vergote, Ignace, Lester, Jenny, Karlan, Beth Y., Heitz, Florian, du Bois, Andreas, Harter, Philipp, Schwaab, Ira, Bean, Yukie, Pejovic, Tanja, Levine, Douglas A., Goodman, Marc T., Camey, Michael E., Thompson, Pamela J., Lurie, Galina, Shildkraut, Joellen, Berchuck, Andrew, Terry, Kathryn L., Cramer, Daniel W., Norris, Murray D., Haber, Michelle, MacGregor, Stuart, deFazio, Anna, Chenevix-Trench, Georgia
Publicado em 2013